Author

Benjamin T. Zandstra

University of Minnesota

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Carly BaehriD· 1 shared Dustin HicksiD· 1 shared Geoffrey T. HartiD· 1 shared J. Sjef VerbeekiD· 1 shared Jenna K. DickiD· 1 shared Jules A. SangalaiD· 1 shared Marco PravetoniiD· 1 shared Mark Steven CraggiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Carly BaehrORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ACE2 decoy Fc-fusions and bi-specific killer engager (BiKEs) require Fc engagement for in vivo efficacy against SARS-CoV-2

Jenna K. Dick, Venkatramana Divana Krishna, Dustin Hicks, Jules A. Sangala, Robert J. Oldham, Benjamin T. Zandstra, Carly Baehr, J. Sjef Verbeek, Mark Steven Cragg, Marco Pravetoni, Maxim C.‐J. Cheeran, Geoffrey T. Hart

This study shows that Fc receptor engagement is necessary for the efficacy of SARS-CoV-2 therapeutics, including mAbs and BiKEs, and demonstrates the effectiveness of ACE2 decoy Fc-fusions and BiKEs against multiple variants.

The Journal of Immunology · Aug 1, 2026Peer-reviewedImmunology